Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2001

Study Completion Date

March 31, 2003

Conditions
Mycoses
Interventions
DRUG

Voriconazole

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00015665 - Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections | Biotech Hunter | Biotech Hunter